ProShare Advisors’s ADMA Biologics ADMA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.11M | Sell |
60,789
-4,092
| -6% | -$74.5K | ﹤0.01% | 785 |
|
|
2025
Q1 | $1.29M | Sell |
64,881
-14,405
| -18% | -$286K | ﹤0.01% | 751 |
|
|
2024
Q4 | $1.36M | Buy |
79,286
+18,375
| +30% | +$315K | ﹤0.01% | 801 |
|
|
2024
Q3 | $1.22M | Buy |
60,911
+18,048
| +42% | +$361K | ﹤0.01% | 763 |
|
|
2024
Q2 | $479K | Sell |
42,863
-11,430
| -21% | -$128K | ﹤0.01% | 1003 |
|
|
2024
Q1 | $358K | Buy |
54,293
+4,570
| +9% | +$30.2K | ﹤0.01% | 1301 |
|
|
2023
Q4 | $225K | Buy |
49,723
+7,655
| +18% | +$34.6K | ﹤0.01% | 1574 |
|
|
2023
Q3 | $151K | Buy |
42,068
+290
| +0.7% | +$1.04K | ﹤0.01% | 1549 |
|
|
2023
Q2 | $154K | Buy |
41,778
+1,821
| +5% | +$6.72K | ﹤0.01% | 1602 |
|
|
2023
Q1 | $132K | Sell |
39,957
-231
| -0.6% | -$765 | ﹤0.01% | 1537 |
|
|
2022
Q4 | $156K | Buy |
40,188
+3,184
| +9% | +$12.4K | ﹤0.01% | 1555 |
|
|
2022
Q3 | $90K | Buy |
37,004
+834
| +2% | +$2.03K | ﹤0.01% | 1581 |
|
|
2022
Q2 | $71K | Buy |
36,170
+15,905
| +78% | +$31.2K | ﹤0.01% | 1660 |
|
|
2022
Q1 | $37K | Sell |
20,265
-7,311
| -27% | -$13.3K | ﹤0.01% | 2133 |
|
|
2021
Q4 | $39K | Buy |
+27,576
| New | +$39K | ﹤0.01% | 2309 |
|
|
2021
Q2 | – | Sell |
-17,612
| Closed | -$31K | – | 2369 |
|
|
2021
Q1 | $31K | Buy |
17,612
+3,009
| +21% | +$5.3K | ﹤0.01% | 2252 |
|
|
2020
Q4 | $28K | Sell |
14,603
-6,689
| -31% | -$12.8K | ﹤0.01% | 2079 |
|
|
2020
Q3 | $51K | Sell |
21,292
-686
| -3% | -$1.64K | ﹤0.01% | 1591 |
|
|
2020
Q2 | $64K | Buy |
21,978
+9,905
| +82% | +$28.8K | ﹤0.01% | 1616 |
|
|
2020
Q1 | $35K | Sell |
12,073
-7,579
| -39% | -$22K | ﹤0.01% | 1128 |
|
|
2019
Q4 | $79K | Buy |
+19,652
| New | +$79K | ﹤0.01% | 1715 |
|